Francesc Pons

421 total citations
9 papers, 163 citations indexed

About

Francesc Pons is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Francesc Pons has authored 9 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Francesc Pons's work include Renal cell carcinoma treatment (4 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Urinary and Genital Oncology Studies (3 papers). Francesc Pons is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Urinary and Genital Oncology Studies (3 papers). Francesc Pons collaborates with scholars based in Spain, United States and United Kingdom. Francesc Pons's co-authors include Joaquim Bellmunt, Anna Orsola, Juan Moróte, Maria-Pilar Barretina-Ginesta, Joaquim Raduà, Margarita Romeo, Josep M. Piulats, J. Maria Caminal Mitjana, Nieves Plana and Àngels Fabra and has published in prestigious journals such as European Journal of Cancer, The Oncologist and Expert Opinion on Investigational Drugs.

In The Last Decade

Francesc Pons

9 papers receiving 161 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesc Pons Spain 6 68 41 35 33 33 9 163
Kalpana Devaraj United States 5 64 0.9× 64 1.6× 2 0.1× 68 2.1× 37 1.1× 9 216
Jayson B. Field United States 5 71 1.0× 25 0.6× 3 0.1× 24 0.7× 27 0.8× 8 184
Michele Cohen United States 8 30 0.4× 32 0.8× 9 0.3× 33 1.0× 173 5.2× 11 220
Tae-Beom Kim United States 5 128 1.9× 44 1.1× 4 0.1× 77 2.3× 36 1.1× 5 195
Jerónimo Martínez-García Spain 8 40 0.6× 53 1.3× 21 0.6× 25 0.8× 21 151
Sandrine Richard France 8 30 0.4× 100 2.4× 39 1.2× 46 1.4× 22 188
Clément Dumont France 9 37 0.5× 68 1.7× 35 1.1× 50 1.5× 37 207
Claudia Manini Italy 7 50 0.7× 76 1.9× 56 1.7× 92 2.8× 32 206
Haruko Iwase Japan 8 39 0.6× 32 0.8× 1 0.0× 24 0.7× 21 0.6× 21 162
Emel Ünal Türkiye 6 27 0.4× 35 0.9× 97 2.8× 16 0.5× 45 1.4× 13 162

Countries citing papers authored by Francesc Pons

Since Specialization
Citations

This map shows the geographic impact of Francesc Pons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesc Pons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesc Pons more than expected).

Fields of papers citing papers by Francesc Pons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesc Pons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesc Pons. The network helps show where Francesc Pons may publish in the future.

Co-authorship network of co-authors of Francesc Pons

This figure shows the co-authorship network connecting the top 25 collaborators of Francesc Pons. A scholar is included among the top collaborators of Francesc Pons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesc Pons. Francesc Pons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pons, Francesc, et al.. (2015). Mapping agro-food consumption groups in the city of Barcelona. 4 indexed citations
2.
Bellmunt, Joaquim, Francesc Pons, André P. Fay, et al.. (2014). Sequential Targeted Therapy After Pazopanib Therapy in Patients With Metastatic Renal Cell Cancer: Efficacy and Toxicity. Clinical Genitourinary Cancer. 12(4). 262–269. 10 indexed citations
3.
Bellmunt, Joaquim, Cristina Suárez, Enrique Gallardo, et al.. (2014). Phase I Study of Sunitinib in Combination With Gemcitabine and Capecitabine for First-Line Treatment of Metastatic or Unresectable Renal Cell Carcinoma. The Oncologist. 19(9). 917–918. 4 indexed citations
4.
Romeo, Margarita, Francesc Pons, Maria-Pilar Barretina-Ginesta, & Joaquim Raduà. (2013). Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor. World Journal of Surgical Oncology. 11(1). 13–13. 32 indexed citations
5.
Bellmunt, Joaquim, Francesc Pons, & Anna Orsola. (2013). Molecular determinants of response to cisplatin-based neoadjuvant chemotherapy. Current Opinion in Urology. 23(5). 466–471. 17 indexed citations
6.
Pons, Francesc & Joaquim Bellmunt. (2013). Sunitinib malate in the treatment of urothelial cancer. Expert Opinion on Investigational Drugs. 23(1). 115–124. 4 indexed citations
7.
Pons, Francesc, Nieves Plana, J. Maria Caminal Mitjana, et al.. (2011). Metastatic uveal melanoma. Melanoma Research. 21(3). 217–222. 38 indexed citations
8.
Pons, Francesc, Anna Orsola, Juan Moróte, & Joaquim Bellmunt. (2011). Variant Forms of Bladder Cancer: Basic Considerations on Treatment Approaches. Current Oncology Reports. 13(3). 216–221. 37 indexed citations
9.
Krajewski, Katherine M., Ronan Fougeray, Joaquim Bellmunt, et al.. (2011). Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine. European Journal of Cancer. 48(10). 1495–1502. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026